コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 with the configuration T7 promoter-TIR-regA-His6.
2 n the amino terminal region between Arg5 and His6.
3 d the trapping capacity was ~100 nmol/mg for His6.
4 n reagents phosphine-FLAG and phosphine-FLAG-His6.
5 ce remaining after removal of the C-terminal His6.
8 ty isolation of histidine-tagged Sba1p (Sba1(His6)) after expression in yeast led to coisolation of H
9 Addition of a 6-histidine extension (HisP(His6)) allows a rapid and effective metal affinity purif
10 alysis of the assembly state showed that the His6-alpha and beta subunits released from corresponding
14 -Tyr8 cross-link is formed between N(tau) of His6 and C(beta) of Tyr8, an unprecedented type of cross
15 unction mutations, restoring efficacy to the His6 and d-Phe7 substituted peptides that had lost effic
16 constraint to enhance the beta-turn spanning His6 and D-Phe7, while the pharmacophore group in Arg8 w
17 cytoplasmic domain of MisS were purified as His6 and maltose binding protein fusion proteins, respec
21 rthermore, interaction between purified Sba1(His6) and Hsp90 in yeast extracts was inhibited by the b
22 re important for complex formation with Sba1(His6), and residues in both the N-terminal nucleotide bi
23 issociation constant between poly-His, i.e., His6, and the Fe3O4@Al2O3 MNPs was ~10(-5) M and the tra
24 tagged derivative by precipitation with anti-His6 antibodies and by Co2+ affinity chromatography.
25 n7)-Phe8 (3), Sar1-Arg2-Val3-Tyr4-cyclo(Asp5-His6-Apt7)-Phe8 (4), Sar1-Arg2-Val3-Tyr4-cyclo(Glu5-His6
26 t7)-Phe8 (4), Sar1-Arg2-Val3-Tyr4-cyclo(Glu5-His6-Apt7)-Phe8 (5), Sar1-Arg2-Val3-Tyr4-cyclo-(Cys5-His
28 ds from the N-terminus of the protein, Arg2, His6, Asn8 and Arg10, interact with the base pairs of th
31 vitro exchange studies reveal that when apo-(His6)-beta2 ((His)beta2) is mixed with beta'2, apo-(His)
35 ng an in vitro assembly assay, purified Sba1(His6) bound to Hsp90 only in the presence of adenosine 5
36 in sf-9 cells infected with both p55CDC and His6-BUBR1 recombinant baculoviruses but not in the cell
40 ecombinant baculoviruses, sf-9 cells produce His6-Cdc25C antigen with an additional slower mobility b
41 e mapping shows that His6-Prk phosphorylates His6-Cdc25C at two sites in vitro and that the major pho
43 rom sf-9 cells co-infected with His6-Prk and His6-Cdc25C baculoviruses, but not with His6-PrkK52R and
44 baculoviruses, but not with His6-PrkK52R and His6-Cdc25C baculoviruses, contains a greatly enhanced k
51 vity of the chimeric enzyme, its addition to His6-CDPK alpha (1-398) resulted in activity that was on
52 s activated only 5-fold, but the activity of His6-CDPK alpha (1-398), which retained nearly half of t
53 (His6-eYFP), and His6-tagged collagenase G (His6-ColG), with sizes ranging from 1 to 11 nm, were use
54 The inactive SpoIVFB.Pro-sigma(K)(1-126)-His6 complex was stable during affinity purification and
58 peptides derived from MTII, Ac-Nle-cyclo(Asp-His6-D-Phe7-Arg8-Trp-Lys)-NH2 (a pan-agonist at the mela
59 (NDP-MSH), by first defining the role of the His6-d-Phe7-Arg8-Trp9 residues in receptor activation (E
62 the His6 epitopes did not appear to mediate His6-dependent viral infection, as assessed in two His6
63 ny genes whose expression requires DnaA, and His6-DnaA binds to the promoters of gcrA, ftsZ and podJ
64 ovel cyclic SHU9119 analogues (Ac-Nle4-[Asp5-His6-DNal(2')7-Arg8-Trp9-Lys10]-NH2) modified in positio
69 yme-linked immunosorbent assay and found the His6 epitopes incorporated in HVR2 and HVR5 could bind t
72 in vitro assays, the degradation of purified His6-Epsilon by the His6-LonBs, ClpPBs, and ClpXBs prote
74 -tagged enhanced yellow fluorescent protein (His6-eYFP), and His6-tagged collagenase G (His6-ColG), w
76 Complexes purified from brains of transgenic His6-FLAG-YFP-NL2 mice showed enrichment in the Gene Ont
80 iserum raised against an overexpressed MrpG'-His6 fusion protein showed that MrpG was present in the
81 The BFP assembly complex, containing a BfpB-His6 fusion protein, was chemically cross-linked in situ
82 protein microarrays constructed with double-His6 GFP demonstrated greater detection sensitivity with
83 ution, while the dissociation rate of double-His6 GFP from Ni-NTA chips in SPR (BIAcore) was 10 times
86 activity in cytosolic extracts, and purified His6-GT78 exhibited alpha3GalT-activity toward a synthet
87 applied for detection of antibodies against His6-H5 HA in serum of vaccinated hen using serial 10-fo
91 tracts of a McArdle cell line overexpressing His6-hemagglutinin-tagged, rat APOBEC-1 using metal-chel
96 oposed in which Cu(2+)-His6/His13 and Cu(2+)-His6/His14 sites alternate along the fibril axis on oppo
97 N-terminal-containing His6-tagged insulysin (His6-IDE) with proteinase K led to the initial cleavage
99 The protonation/deprotonation equilibrium of His6 influences the reduction potential of the protein i
103 In contrast to the intact complex, HisP(his6) is not inhibited by vanadate but is inhibited by N
104 nding half-site capable of interacting with (His6)jRXR fusion protein was identified in the promoters
106 -binding (Asp347) residue were essential for His6-LAP-A activity, as most R431 and D347 mutant His6-L
108 Glu334, Arg336, and Lys262, was evaluated in His6-LAP-A fusion proteins expressed in Escherichia coli
114 of Lys354 (a catalytic residue) resulted in His6-LAP-As that cleaved dipeptides at slower rates.
115 reover, LdSec13 specifically interacted with His6-LdSec31(1-603), and LdSec31 bound the prebudding co
117 degradation of purified His6-Epsilon by the His6-LonBs, ClpPBs, and ClpXBs proteases from B. subtili
118 d to estimate the secondary structure of the His6 loop, revealing an ordered folding composed of 23%
119 rther show that purified A. pleuropneumoniae His6-Lrp binds in vitro to the A. pleuropneumoniae promo
125 t7)-Phe8 (6), Sar1-Arg2-Val3-Tyr4-cyclo(Cys5-His6-Mpc7)-Phe8 (7), Sar1-Arg2-Val3-Tyr4-cyclo(Hcy5-His6
126 Phe8 (8), and Sar1-Arg2-Val3-Tyr4-cyclo(Hcy5-His6-Mpc7)-Phe8 (9), where Apt stands for 4-amino-trans-
127 7)-Phe8 (5), Sar1-Arg2-Val3-Tyr4-cyclo-(Cys5-His6-Mpt7)-Phe8 (6), Sar1-Arg2-Val3-Tyr4-cyclo(Cys5-His6
128 c7)-Phe8 (7), Sar1-Arg2-Val3-Tyr4-cyclo(Hcy5-His6-Mpt7)-Phe8 (8), and Sar1-Arg2-Val3-Tyr4-cyclo(Hcy5-
131 t the terminator site, and that MBP-NasR and His6-NasR proteins both caused transcription readthrough
134 ses the immune and inflammatory responses to His6-OPH in vivo as determined by anti-OPH IgG and cytok
135 ic coupling of the hexahistidine tagged OPH (His6-OPH) and poly(ethylene glycol)-b-poly(l-glutamic ac
138 ic and inhibition studies were performed for His6-PDK1(deltaPH)-catalyzed phosphorylation of PDK1-Tid
139 analogs were Sar1-Arg2-Val3-Tyr4-cyclo(Cys5-His6-Pen7)-Phe8 (3), Sar1-Arg2-Val3-Tyr4-cyclo(Asp5-His6
143 Plk3, but not by the kinase-defective mutant His6-Plk3(K52R), GST-p53 was recognized by an antibody s
144 recipitated from sf-9 cells co-infected with His6-Prk and His6-Cdc25C baculoviruses, but not with His
148 Moreover, phosphopeptide mapping shows that His6-Prk phosphorylates His6-Cdc25C at two sites in vitr
150 and His6-Cdc25C baculoviruses, but not with His6-PrkK52R and His6-Cdc25C baculoviruses, contains a g
151 His6-Prk, but not a kinase-defective mutant His6-PrkK52R, is capable of strongly phosphorylating His
152 angiotensin II (Asp1-Arg2-Val3-Tyr4-Val/IIe5-His6-Pro7-Phe8, AII), the synthesis and biological testi
153 T7 promoter on plasmid pSA1 yielded a RegA69-His6 protein that binds nickel-Sepharose and elutes with
156 stidine6-tagged receptor-associated protein (His6-RAP) with high affinity, although variants lacking
157 siRNA to C33-A cells using oligofectamine or His6 reducible polymers, siRNA uptake was quantified by
158 gene products in which C-terminal tags (FLAG-His6) replace the native glycosylphosphatidylinositol an
160 of Ad type 2 E3-19K tagged with a C-terminal His6 sequence in baculovirus-infected insect cells.
162 at their amino terminus, the peptide Met Gly His6 Ser Gly Leu Phe Lys Arg/, where Leu Phe Lys Arg/ is
163 opose that removing the interaction with the His6 side chain reorients the peptide within the binding
170 fouling properties were then used to isolate His6-T7 bacteriophage and His6-GroEL directly from cell
171 s formed between 1-Cys Prx with a C-terminal His6 tag and GST pi upon incubation of the two proteins
172 engineered into an expression vector with a His6 tag at its amino terminus, and the protein was expr
173 ombinant alpha-galactosidase molecule with a His6 tag at its C-terminus was constructed by an overlap
180 ary of mutants whose combined members have a His6 tag inserted at likely every site in the original p
182 modified surfaces than a conventional single-His6 tag or two single-His6 tags at N- and C-termini.
187 NBD1-R (amino acids 404-830, in fusion with His6 tag) were expressed as single proteins in Escherich
189 9-kDa chimeric proteins, having a C-terminal His6 tag, were secreted by Saccharomyces cerevisiae, usi
194 GFP), stable and tight binding of the double-His6 tag/Ni-NTA interaction was demonstrated by competit
195 Here we describe a double-hexahistidine (His6) tag sequence, comprising two hexahistidines separa
196 1 KCS and its mutants were engineered with a His6-tag at their N-terminus, and expressed in Saccharom
197 on in conjunction with immobilized metal ion/His6-tag interactions to prepare highly purified recombi
201 in Escherichia coli as catalytically active His6 tagged proteins, purified to homogeneity by affinit
207 mbinant sorcin bound to cardiac and skeletal HIS6-tagged alpha1 C termini immobilized on Ni2+ resin.
210 ypothesis, R. sphaeroides mutants expressing His6-tagged bc1 complexes with mutations at three aromat
211 yellow fluorescent protein (His6-eYFP), and His6-tagged collagenase G (His6-ColG), with sizes rangin
214 latory protein was purified as an N-terminal His6-tagged derivative and characterised both with and w
218 spectrometry confirmed production of intact, His6-tagged forms of CYP144A1-FLV and -TRV, with EPR dem
220 6E mutants of peripherin-2 were expressed as His6-tagged full-length proteins in Madin-Darby canine k
223 The protocol described here uses recombinant His6-tagged KDPG aldolase for the synthesis of (S)-4-hyd
231 d-biotin-tris-NTA (BTN) hybrid compound, any His6-tagged protein can be immobilized on the surface of
232 proteins in the same cell and isolating the His6-tagged protein followed by MutS immunoblotting afte
233 RNA ligands were selected by binding to His6-tagged proteins and chromatography on nickel(II) ni
237 formation by wild-type and mutant XRCC3 with His6-tagged Rad51C upon co-expression in bacteria, nicke
238 n investigated by Raman spectroscopy using a His6-tagged recombinant protein that self-assembles in v
239 These proteins have been expressed as Met-His6-tagged recombinant proteins and purified by metal c
245 ecifically recognizing Rpl17 or Rpl39, and a His6-tagged version of Rpl4, we established that all thr
248 e-steady-state studies were performed on the His6-tagged wild-type (WT) enzyme, several active site m
251 that encode the PAS domain with and without His6 tags and expressed the PAS peptides in E. coli.
254 quipped lipid to bind the proteins via their His6-tags to the lipid membrane were used to bind two di
255 This deletion reduced multimerization of His6-tailed KorB protein in vitro and greatly reduced bi
257 as equipped with a C-terminal hexahistidine (His6) tether to facilitate the assembly on betaCD surfac
259 otein with one of eight tags: hexahistidine (His6), thioredoxin (Trx), small ubiquitin-related modifi
267 s led to the identification of several VSV-G-His6 variants that were able to package high-titer viral
270 se-insensitive protein variant (FixK2(C183S)-His6) was used in which Cys-183 was replaced with serine
273 ng recombinant Shiga-like toxins tagged with His6 were used as the samples to further demonstrate tha